已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Studies on CEBPA mutations in acute myeloid leukaemia

作者
Green Cl
出处
期刊:University College London - UCL Discovery [University College London]
摘要

Acute myeloid leukaemia (AML) is a highly heterogeneous disease with regard to clinical outcome, and molecular markers with prognostic impact can be used to stratify patients for risk-adapted therapy. CEBPA mutations have been associated with a favourable prognosis, however several questions remained, in particular whether one (CEBPA-single) or two (CEBPA-double) mutations were necessary for this benefit, and their interaction with other molecular markers. A method of detecting CEBPA mutations in patient samples using denaturing HPLC was developed and the CEBPA status of 1427 young adult AML patients (median age 43 years, range 15-68 years) determined. Overall, 107 (7%) were CEBPA-mutant: 48 (45%) CEBPA-single and 59 (55%) CEBPA-double. The majority of CEBPA-double patients (83%) had an out-of-frame insertion/deletion in the N-terminus and a mutation in the C-terminal DNA-binding/leucine zipper domains (DBD/LZD) that were on different alleles as determined by cloning. By contrast, mutations in CEBPA-single cases were distributed across the gene. CEBPA-double patients were less likely to have a FLT3/ITD (P=.04) and highly unlikely to have an NPM1 mutation (P<.0001) compared to CEBPA-WT/CEBPA-single cases. Eight year overall survival (OS) was higher in CEBPA-double patients compared to CEBPA-WT and CEBPA-single cases (54%, 34%, 31%, respectively, P=.004). In multivariate analyses, CEBPA-double, but not CEBPA-single, was an independent favourable factor for OS (P=.004) and relapse (P=.02). However, this benefit was completely lost in the presence of a FLT3/ITD. The mutant level of 101 mutations was determined by fragment analysis and the majority were of a level consistent with a heterozygous mutation present in most cells. The impact of ten atypical CEBPA mutations on C/EBPα transactivation activity was explored by a luciferase reporter assay. Only mutations affecting the DBD or LZD functional domains had an impact on transactivation activity. This work provides insight into the biology of CEBPA mutations and their use as clinical markers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
汤圆完成签到,获得积分10
5秒前
阳光萝完成签到,获得积分10
6秒前
榆树皮面完成签到,获得积分10
6秒前
7秒前
10秒前
alex的应助被开放的小Q采纳,获得10
13秒前
小巧的面包完成签到 ,获得积分10
16秒前
飘逸小之发布了新的文献求助10
16秒前
陈陈潇完成签到,获得积分20
17秒前
17秒前
xr完成签到,获得积分10
18秒前
19秒前
踏实乐枫发布了新的文献求助10
22秒前
xr发布了新的文献求助10
23秒前
23秒前
24秒前
24秒前
25秒前
粗心的小鸽子完成签到,获得积分10
25秒前
跳跃的正豪完成签到,获得积分10
26秒前
yao发布了新的文献求助10
26秒前
gbh完成签到 ,获得积分20
28秒前
子皿发布了新的文献求助10
28秒前
ccccc完成签到 ,获得积分10
29秒前
moriaty发布了新的文献求助20
30秒前
自信的寄松完成签到 ,获得积分10
32秒前
专注的夜天完成签到,获得积分10
36秒前
gzghgzh完成签到,获得积分10
37秒前
菲菲完成签到 ,获得积分10
38秒前
科研通AI6.4的应助被开朗向彤采纳,获得10
39秒前
顾矜的应助被科研通管家采纳,获得10
40秒前
Owen的应助被科研通管家采纳,获得10
40秒前
彭于晏的应助被科研通管家采纳,获得10
40秒前
vc驳回了Maestro_S的应助
40秒前
桐桐的应助被科研通管家采纳,获得10
40秒前
JamesPei的应助被科研通管家采纳,获得10
40秒前
FashionBoy的应助被科研通管家采纳,获得10
41秒前
bkagyin的应助被科研通管家采纳,获得10
41秒前
41秒前
DW的应助被科研通管家采纳,获得10
41秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184917
求助须知:如何正确求助?哪些是违规求助? 9573843
关于积分的说明 21833352
捐赠科研通 7782304
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558581
邀请新用户注册赠送积分活动 2481082